BEEBE KATHERINE enters TITAN PHARMACEUTICALS INC with 2.39K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/25/2019ACC: 0001144204-19-009923
Officer· Chief Scientific Officer
Since Feb 2019
2.39K
Baseline shares
100% direct
2.39K
Direct ownership
1 position
61.06K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2.39K
Total
2.39K direct2.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.39K | Direct |
| Total | 2.39K | 2.39K direct |
Derivative Holdings3
Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
28.34K
Shares owned
N/A
Exercise price
5.82
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
4.24K
Shares owned
N/A
Exercise price
19.80
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
28.49K
Shares owned
N/A
Exercise price
1.56
Expiration
—
Exercise window
—
Total
Underlying
61.06K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option (Right to Buy) Direct | Common Stock | 5.82 | — | — | 28.34K | N/A |
| Option (Right to Buy) Direct | Common Stock | 19.80 | — | — | 4.24K | N/A |
| Option (Right to Buy) Direct | Common Stock | 1.56 | — | — | 28.49K | N/A |
| Total | 61.06K | 0.00 | ||||